A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) Versus Treatment of Investigator's Choice (IC) in Patients With Platinum Resistant Ovarian Cancer
Categories (click each to see list of all clinical trials associated with that category): Gyn/Onc (OB/GYNONC)
Current Status: Open
Phase: III (Cancer Control)
Principal Investigator: McAlarnen, Lindsey
Contact Information:
Erin Doherty
erin.doherty@unmc.edu
Summary